众生药业：昂拉地韦颗粒III期临床试验正在积极推进中 目前已完成全部参与者入组工作

Group 1 - The company is actively advancing the Phase III clinical trial of Anglatide granules and has completed the enrollment of all participants [2] - The company aims to complete the relevant research as soon as possible and apply for drug approval to provide more treatment options for patients [2] - The company will strictly adhere to relevant rules and requirements in fulfilling decision-making procedures and information disclosure obligations [2]